Therapeutics of Natural and Synthetic Compounds in Protease Induced Cancer presents a detailed discussion on the role of therapeutic and synthetic compounds in proteases and how they have been utilized to develop anticancer drugs, covering both their structure and functions. In addition, the book explores the experimental and theoretical aspects of natural and synthetic compound design based on proteases. Sections bridge the gap between fundamental and translational research, with applications in the biomedical and pharmaceutical industry, making it a thought-provoking read for basic and…mehr
Therapeutics of Natural and Synthetic Compounds in Protease Induced Cancer presents a detailed discussion on the role of therapeutic and synthetic compounds in proteases and how they have been utilized to develop anticancer drugs, covering both their structure and functions. In addition, the book explores the experimental and theoretical aspects of natural and synthetic compound design based on proteases. Sections bridge the gap between fundamental and translational research, with applications in the biomedical and pharmaceutical industry, making it a thought-provoking read for basic and applied scientists engaged in biomedical research. In 23 chapters, this book gives both insights on the general aspects of the role of natural and synthetic compounds in cancer therapeutics, in cancer development, treatment, and their use in clinical trails. Given the breadth and depth of information covered in the respective contributions, the book will be immensely useful for researchers in oncology and for those working to identify targets for drug development.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
A. General Aspects 1. Therapeutic aspects of urokinase-plasminogen activator system in cancer 2. The role of acetylcholinesterase in cancer development and possible therapeutic applications by natural and synthetic compounds. 3. Influence of serine proteases on bone morphogenetic proteins: Insights for advancing treatment paradigm in breast cancer 4. Structural insights of proteases in cancer therapy perspectives B. Role of Synthetic Compounds 5. Role of Boron containing synthetic compounds as serine proteases inhibitors in prostate cancer 6. Exploring Synthetic and Natural Compounds for Cathepsin B-mediated Breast Cancer: Mechanisms and Therapy Responses C. Role of Natural Compounds 7. Flavonoids containing phytochemicals as protease inhibitors in cancer chemoprevention 8. Dietary proteases and their connection to cancer 9. Natural compounds as potential cancer therapeutics: A focus on curcumin and resveratrol 10. Snake venom proteases as potential cancer therapeutics 11. Autophagy Inhibition with Plant-Derived Alkaloids in Cancer Treatment: From Molecular Mechanisms to Targeted Therapy 12. From Naturally-sourced aspartic and metalloproteases inhibitors to therapeutic aspects of skin cancer 13. Compounds of plant origin as therapeutics for serine protease implicated in colorectal cancer 14. Plant peptides and proteins as protease inhibitors in breast cancer therapy 15. Exploring the Potentials of Genistein, Lycopene, Ellagic acid as Protease Inhibitors in Cancer Therapeutics 16. Modulation of serine proteases in liver cancer by quercetin - a therapeutic perspective 17. Role of natural bioactive small molecules as inhibitors for cysteine proteases in cancer 18. Natural compounds as inhibitors of MMPs 19. A Comprehensive Overview of Epigallocatechin Gallate and Its Role in Human Osteosarcoma inhibition. 20. Exploring the natural repository of serine protease inhibitors for cancer therapeutics D. Protease inhibitors in Clinical Trials 21. Inhibitors of matrix metalloproteinases in clinical trials 22. Breast cancer therapeutics by protease inhibitors 23. Clinical trials on the efficacy of anticancer protease inhibitors on breast, prostate, lung
A. General Aspects 1. Therapeutic aspects of urokinase-plasminogen activator system in cancer 2. The role of acetylcholinesterase in cancer development and possible therapeutic applications by natural and synthetic compounds. 3. Influence of serine proteases on bone morphogenetic proteins: Insights for advancing treatment paradigm in breast cancer 4. Structural insights of proteases in cancer therapy perspectives B. Role of Synthetic Compounds 5. Role of Boron containing synthetic compounds as serine proteases inhibitors in prostate cancer 6. Exploring Synthetic and Natural Compounds for Cathepsin B-mediated Breast Cancer: Mechanisms and Therapy Responses C. Role of Natural Compounds 7. Flavonoids containing phytochemicals as protease inhibitors in cancer chemoprevention 8. Dietary proteases and their connection to cancer 9. Natural compounds as potential cancer therapeutics: A focus on curcumin and resveratrol 10. Snake venom proteases as potential cancer therapeutics 11. Autophagy Inhibition with Plant-Derived Alkaloids in Cancer Treatment: From Molecular Mechanisms to Targeted Therapy 12. From Naturally-sourced aspartic and metalloproteases inhibitors to therapeutic aspects of skin cancer 13. Compounds of plant origin as therapeutics for serine protease implicated in colorectal cancer 14. Plant peptides and proteins as protease inhibitors in breast cancer therapy 15. Exploring the Potentials of Genistein, Lycopene, Ellagic acid as Protease Inhibitors in Cancer Therapeutics 16. Modulation of serine proteases in liver cancer by quercetin - a therapeutic perspective 17. Role of natural bioactive small molecules as inhibitors for cysteine proteases in cancer 18. Natural compounds as inhibitors of MMPs 19. A Comprehensive Overview of Epigallocatechin Gallate and Its Role in Human Osteosarcoma inhibition. 20. Exploring the natural repository of serine protease inhibitors for cancer therapeutics D. Protease inhibitors in Clinical Trials 21. Inhibitors of matrix metalloproteinases in clinical trials 22. Breast cancer therapeutics by protease inhibitors 23. Clinical trials on the efficacy of anticancer protease inhibitors on breast, prostate, lung
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826